John Boylan
Stock Analyst at William Blair
(2.82)
# 1,635
Out of 5,157 analysts
8
Total ratings
100%
Success rate
27.64%
Average return
Main Sectors:
Stocks Rated by John Boylan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Initiates: Outperform | n/a | $71.39 | - | 1 | Mar 10, 2026 | |
| CI The Cigna Group | Downgrades: Hold | n/a | $260.87 | - | 1 | Aug 18, 2023 | |
| GEHC GE HealthCare Technologies | Initiates: Hold | n/a | $72.65 | - | 1 | Jan 4, 2023 | |
| SYK Stryker | Upgrades: Buy | n/a | $345.78 | - | 1 | Jul 28, 2022 | |
| SYY Sysco | Upgrades: Buy | n/a | $84.56 | - | 2 | Sep 10, 2020 | |
| HSY The Hershey Company | Upgrades: Buy | n/a | $217.85 | - | 2 | Mar 25, 2020 |
BridgeBio Pharma
Mar 10, 2026
Initiates: Outperform
Price Target: n/a
Current: $71.39
Upside: -
The Cigna Group
Aug 18, 2023
Downgrades: Hold
Price Target: n/a
Current: $260.87
Upside: -
GE HealthCare Technologies
Jan 4, 2023
Initiates: Hold
Price Target: n/a
Current: $72.65
Upside: -
Stryker
Jul 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $345.78
Upside: -
Sysco
Sep 10, 2020
Upgrades: Buy
Price Target: n/a
Current: $84.56
Upside: -
The Hershey Company
Mar 25, 2020
Upgrades: Buy
Price Target: n/a
Current: $217.85
Upside: -